Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain

Influenza is a viral respiratory disease that causes significant clinical and economic burden globally. Quadrivalent influenza vaccine (QIV) is frequently used to protect people who have a high-risk of developing influenza complications due to comorbidities. QIV offers protection against influenza A...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez, Piedad Alvarez
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2020-09-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	influenza vaccination spain quadrivalent influenza vaccine (qiv) cost-effectiveness cell-based vaccines high-risk burden of illness
Accés en línia:	http://dx.doi.org/10.1080/21645515.2020.1712935
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!